Suppr超能文献

硬皮病样纤维化疾病

Scleroderma-like fibrosing disorders.

作者信息

Boin Francesco, Hummers Laura K

机构信息

Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Room 405, Baltimore, MD 21224, USA.

出版信息

Rheum Dis Clin North Am. 2008 Feb;34(1):199-220; ix. doi: 10.1016/j.rdc.2007.11.001.

Abstract

Many conditions presenting with clinical hard skin and tissue fibrosis can be confused with systemic sclerosis (scleroderma). These disorders have very diverse etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow one to distinguish these conditions from scleroderma and from each other. A prompt diagnosis is important to spare patients from ineffective treatments and inadequate management. This article highlights nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy), eosinophilic fasciitis (Shulman's syndrome), scleromyxedema, and scleredema. These often are detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.

摘要

许多表现为临床硬皮和组织纤维化的病症可能会与系统性硬化症(硬皮病)相混淆。这些疾病病因极为多样,发病机制往往也不明确。不同的临床特征、皮肤组织学表现及疾病关联可能有助于将这些病症与硬皮病区分开来,也有助于相互鉴别。及时诊断对于避免患者接受无效治疗和管理不当至关重要。本文重点介绍了肾源性系统性纤维化(肾源性纤维化皮肤病)、嗜酸性筋膜炎(舒尔曼综合征)、硬化性黏液水肿和硬化性水肿。这些病症常在初级保健机构中被发现,并转诊给风湿病学家做进一步评估。风湿病学家必须能够迅速识别它们,以便为受影响的患者提供有价值的预后信息和合适的治疗方案。

相似文献

1
Scleroderma-like fibrosing disorders.
Rheum Dis Clin North Am. 2008 Feb;34(1):199-220; ix. doi: 10.1016/j.rdc.2007.11.001.
2
Scleroderma mimics.
Curr Rheumatol Rep. 2012 Feb;14(1):39-46. doi: 10.1007/s11926-011-0220-8.
3
[Sclerosing skin diseases].
Internist (Berl). 2019 Aug;60(8):783-791. doi: 10.1007/s00108-019-0643-2.
4
Localized cutaneous fibrosing disorders.
Rheum Dis Clin North Am. 2013 May;39(2):347-64. doi: 10.1016/j.rdc.2013.02.013. Epub 2013 Mar 16.
5
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4.
6
Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.
Rheumatol Int. 2010 Aug;30(10):1389-91. doi: 10.1007/s00296-009-1083-4. Epub 2009 Aug 20.
7
Morphological clues in the diagnosis of sclerodermiform dermatitis.
Am J Dermatopathol. 2014 Jun;36(6):449-64. doi: 10.1097/DAD.0000000000000049.
8
Quiz page February 2008: A hemodialysis patient with thickened skin. Nephrogenic fibrosing dermopathy.
Am J Kidney Dis. 2008 Feb;51(2):A33-4. doi: 10.1053/j.ajkd.2007.12.001.
10
[Mimetics of systemic sclerosis].
Z Rheumatol. 2019 Feb;78(1):14-23. doi: 10.1007/s00393-018-0538-y.

引用本文的文献

1
Scleredema Adultorum of Buschke Associated With Diffuse Eosinophilia and Hepatitis B Virus Infection.
Cureus. 2023 Apr 29;15(4):e38300. doi: 10.7759/cureus.38300. eCollection 2023 Apr.
2
Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey.
Case Rep Dermatol. 2022 Jun 27;14(2):178-183. doi: 10.1159/000525211. eCollection 2022 May-Aug.
4
Systemic Sclerosis: Current State and Survival After Lung Transplantation.
Cureus. 2021 Jan 20;13(1):e12797. doi: 10.7759/cureus.12797.
5
Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.
J Invest Dermatol. 2019 Oct;139(10):2134-2143.e2. doi: 10.1016/j.jid.2019.03.1145. Epub 2019 Apr 9.
7
Long-term benefit of electron beam radiation therapy in the treatment of scleredema of Buschke.
Adv Radiat Oncol. 2015 Dec 9;1(1):21-25. doi: 10.1016/j.adro.2015.11.002. eCollection 2016 Jan-Mar.
8
Scleroderma Mimickers.
Curr Treatm Opt Rheumatol. 2016 Mar;2(1):69-84. doi: 10.1007/s40674-016-0038-7. Epub 2016 Feb 5.
10
Reactive oxygen species and fibrosis: further evidence of a significant liaison.
Cell Tissue Res. 2016 Sep;365(3):591-605. doi: 10.1007/s00441-016-2445-3. Epub 2016 Jun 27.

本文引用的文献

1
Imatinib mesylate treatment of nephrogenic systemic fibrosis.
Arthritis Rheum. 2008 Aug;58(8):2543-8. doi: 10.1002/art.23696.
2
Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
Arch Dermatol. 2007 Aug;143(8):1025-30. doi: 10.1001/archderm.143.8.1025.
4
Deep morphea.
Semin Cutan Med Surg. 2007 Jun;26(2):90-5. doi: 10.1016/j.sder.2007.02.005.
5
Gadolinium and nephrogenic systemic fibrosis.
Kidney Int. 2007 Aug;72(3):260-4. doi: 10.1038/sj.ki.5002338. Epub 2007 May 16.
7
Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
Invest Radiol. 2007 Feb;42(2):139-45. doi: 10.1097/01.rli.0000253505.88945.d5.
8
Scleromyxoedema treated with autologous stem cell transplantation.
J Eur Acad Dermatol Venereol. 2007 Jan;21(1):129-30. doi: 10.1111/j.1468-3083.2006.01814.x.
9
Scleromyxedema: successful treatment with thalidomide in two patients.
Dermatology. 2007;214(1):58-60. doi: 10.1159/000096914.
10
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
J Am Acad Dermatol. 2007 Jan;56(1):21-6. doi: 10.1016/j.jaad.2006.10.047. Epub 2006 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验